	流動資産		日付
AbbVie	USD 29.06B	523M	2025-12
Alterity Therapeutics Limited	AUD 27.05M	6.16M	2023-06
Amgen	USD 29.06B	1.17B	2025-12
AstraZeneca	USD 28.72B	1.22B	2025-12
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Cipla	INR 249.18B	16.3B	2025-09
Clal Biotechnology	ILS 14.69M	1.95M	2023-12
Compugen	USD 88.92M	8.72M	2025-09
CSL	USD 11.85B	1000K	2025-12
Eisai	JPY 840.88B	50.18B	2025-12
Eli Lilly	USD 55.63B	6.44B	2025-12
Gilead Sciences	USD 19.89B	1.05B	2025-12
GlaxoSmithKline	GBP 17.51B	332M	2025-12
Grifols	EUR 6.28B	92.48M	2025-09
Incyte	USD 5.02B	746.01M	2025-12
Infinity Pharmaceuticals	USD 19.91M	8.46M	2023-06
Ionis Pharmaceuticals	USD 2.99B	471.01M	2025-12
J&J	USD 55.62B	1.01B	2025-12
Novartis	USD 28.2B	2.26B	2025-09
Pfizer	USD 46.92B	3.22B	2025-09
Plus Therapeutics	USD 9.83M	1.75M	2023-12
Roche Holding	CHF 38.73B	3.03B	2025-12
TG Therapeutics	USD 630.76M	31M	2025-12